Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Melanoma/Skin Cancer
•
Dermatology
Are there certain patient characteristics that drive you to recommend intralesional 5-FU or MTX for a large SCC on the back?
Related Questions
How frequently do you recommend skin cancer screens in your patients with kidney transplants who are on immunosuppression?
Would you favor radiation or immune modulating treatment like imiquimod to treat an uncomplicated basal cell carcinoma on the nose in an elderly patient for whom you'd like to avoid surgery?
How would you treat a basal cell carcinoma on the temporal skin and zygomatic area s/p excision with PNI and significant flaps for closure?
What is your preferred treatment for actinic cheilitis?
Do computerized mole-mapping tools play a role in your clinical practice?
What chemoprophylaxis, if any, would you consider in a transplant patient with numerous KC/NMSCs?
What patient characteristics or clinical scenarios guide the decision in performing slow Mohs procedures?
Do you obtain MRI for cutaneous SCC with microscopic PNI to assess for gross perineural tumor spread?
How do you approach patients with advanced resectable basal cell carcinoma for possible use of hedgehog inhibitors?
Is narrow-band ultraviolet B (nbUVB) phototherapy contraindicated or recommended with caution in patients with a personal history of melanoma?
